X34 Stock Overview
Provides home health and hospice services in the United States. More details
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 3/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
No risks detected for X34 from our risk checks.
My Notes
Capture your thoughts, links and company narrative
Enhabit, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$7.35 |
| 52 Week High | US$10.60 |
| 52 Week Low | US$6.10 |
| Beta | 1.44 |
| 1 Month Change | 8.89% |
| 3 Month Change | 3.52% |
| 1 Year Change | -23.04% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -44.74% |
Recent News & Updates
Recent updates
Shareholder Returns
| X34 | DE Healthcare | DE Market | |
|---|---|---|---|
| 7D | -8.7% | -3.5% | -2.6% |
| 1Y | -23.0% | 15.6% | 6.9% |
Return vs Industry: X34 underperformed the German Healthcare industry which returned 16% over the past year.
Return vs Market: X34 underperformed the German Market which returned 7.1% over the past year.
Price Volatility
| X34 volatility | |
|---|---|
| X34 Average Weekly Movement | 5.6% |
| Healthcare Industry Average Movement | 4.7% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 11.3% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: X34 has not had significant price volatility in the past 3 months compared to the German market.
Volatility Over Time: X34's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1998 | 10,800 | Barb Jacobsmeyer | www.ehab.com |
Enhabit, Inc. provides home health and hospice services in the United States. Its home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer’s disease, low vision, spinal stenosis, Parkinson’s disease, osteoporosis, complex wound care and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery, or injury and respiratory diseases; and physical, occupational and speech therapists provide therapy services. The company offers hospice services, including pain and symptom management, palliative and dietary counseling, social worker visits, spiritual counseling, and bereavement counseling services to meet the individual physical, emotional, spiritual, and psychosocial needs of terminally ill patients and their families.
Enhabit, Inc. Fundamentals Summary
| X34 fundamental statistics | |
|---|---|
| Market cap | €371.08m |
| Earnings (TTM) | -€111.75m |
| Revenue (TTM) | €994.05m |
0.4x
P/S Ratio-3.3x
P/E RatioIs X34 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| X34 income statement (TTM) | |
|---|---|
| Revenue | US$1.04b |
| Cost of Revenue | US$531.20m |
| Gross Profit | US$506.00m |
| Other Expenses | US$622.60m |
| Earnings | -US$116.60m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -2.32 |
| Gross Margin | 48.79% |
| Net Profit Margin | -11.24% |
| Debt/Equity Ratio | 86.8% |
How did X34 perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/20 13:47 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Enhabit, Inc. is covered by 12 analysts. 7 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Joanna Sylvia Gajuk | BofA Global Research |
| Jason Cassorla | Citigroup Inc |
| Lawrence Solow | CJS Securities, Inc. |